Skip to main content

Table 3 Availability of insulin in Bengaluru’s private-sector retail pharmacies based on type, delivery device and company type

From: Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study

a. Private-sector retail pharmacies [N = 30]
Insulin type and delivery device Company Type
Indian Non-Indian Combined (Indian & Non-Indian)
Human insulin (overall) 73.3% (n = 22) 96.7% (n = 29) 96.7% (n = 29)
 Vial
  40 IU/ml 66.7% (n = 20) 96.7% (n = 29) 96.7% (n = 29)
  100 IU/ml 50.0% (n = 15) 43.3% (n = 13) 66.7% (n = 20)
 Cartridge
  40 IU/ml 0.0% (n = 0) 0.0% (n = 0) 0.0% (n = 0)
  100 IU/ml 0.0% (n = 0) 30.0% (n = 9) 30.0% (n = 9)
 Pen
  40 IU/ml 0.0% (n = 0) 0.0% (n = 0) 0.0% (n = 0)
  100 IU/ml 0.0% (n = 0) 36.6% (n = 11) 36.7% (n = 11)
Analogue insulin (overall) 26.7% (n = 8) 76.7% (n = 23) 80.0% (n = 24)
 Vial
  40 IU/ml 0.0% (n = 0) 0.0% (n = 0) 0.0% (n = 0)
  100 IU/ml 20.0% (n = 6) 0.0% (n = 0) 20.0% (n = 6)
 Cartridge
  40 IU/ml 0.0% (n = 0) 0.0% (n = 0) 0.0% (n = 0)
  100 IU/ml 10.0% (n = 3) 30.0% (n = 9) 33.3% (n = 10)
 Pen
  40 IU/ml 0.0% (n = 0) 0.0% (n = 0) 0.0% (n = 0)
  100 IU/ml 0.0% (n = 0) 73.3% (n = 22) 73.3% (n = 22)
b. Public-sector hospital pharmacies [N = 5]
Human insulin (overall) 80.0% (n = 4) 60.0% (n = 3) 80.0% (n = 4)
 Vial
  40 IU/ml 80.0% (n = 4) 60.0% (n = 3) 80.0% (n = 4)
  100 IU/ml 60.0% (n = 3) 20.0% (n = 1) 60.0% (n = 3)
 Cartridge
  100 IU/ml 0.0% (n = 0) 20.0% (n = 1) 20.0% (n = 1)
 Pen
  100 IU/ml 0.0% (n = 0) 20.0% (n = 1) 20.0% (n = 1)
Analogue insulin (overall) 40.0% (n = 2) 40.0% (n = 2) 60.0% (n = 3)
 Vial
  40 IU/ml 0.0% (n = 0) 0.0% (n = 0) 0.0% (n = 0)
  100 IU/ml 40.0% (n = 2) 0.0% (n = 0) 40.0% (n = 2)
 Cartridge
  100 IU/ml 0.0% (n = 0) 20.0% (n = 1) 20.0% (n = 1)
 Pen
  100 IU/ml 0.0% (n = 0) 40.0% (n = 2) 40.0% (n = 2)